Lindsay Foust, DPM
Podiatrist · Paris, TNNPI 1609152230
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 43.1% of the total. Reporting peaked in 2019 at $3,828 and has fallen 75.3% since, to $946 in 2025.
Across 83 payments — averaging $105.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Gentleman Orthopedic Solutions$3K
- Treace Medical Concepts, Inc.$1K
- Averitas Pharma Inc.$111
- Amgen$109
- Smith+Nephew$63
- plus $326 from 12 others
What the payments were for
- Travel & lodging$1,73020%
- Food & beverage$2,26626%
- Education$4,77254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 27 | $3,783 |
| Gentleman Orthopedic Solutions | 11 | $3,363 |
| Treace Medical Concepts, Inc. | 12 | $1,013 |
| Averitas Pharma Inc. | 4 | $111 |
| Amgen(2 entities) | 8 | $109 |
| Smith+Nephew | 4 | $63 |
| Kerecis Limited | 1 | $49 |
| Bioventus LLC | 3 | $49 |
| GSK | 2 | $46 |
| Stryker | 1 | $33 |
| Polarityte, Inc. | 2 | $25 |
| Melinta Therapeutics, LLC | 1 | $25 |
| KCI USA, Inc. | 2 | $24 |
| Innovation Technologies Inc | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $15 |
| DJO, LLC | 1 | $12 |
| Heraeus Medical, LLC. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,769 in reported general payments places this provider in the 85th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $9,361 |
| Ammonium Lactate | 59 | $919 |
| Diclofenac Sodium | 75 | $802 |
| Methylprednisolone | 69 | $458 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $419 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $381 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $269 |
| Mupirocin | 42 | $263 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $253 |
| Cephalexin | 20 | $152 |
| Doxycycline Hyclate | 17 | $152 |
| Ibuprofen | 14 | $147 |
| Meloxicam | 68 | $124 |
| Ketoconazole | 13 | $97 |
| Triamcinolone Acetonide | 19 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $63 | $9,36113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 podiatrist providers in Tennessee.
Other podiatrist in Paris
- David LongParis$738
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
- Christopher HendrixBartlett$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.